• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
WEI Yiwen,QIU Han.Analysis of literatures about drug-induced death caused by cephalosporins from 2005 to 2014[J].Journal Of Pharmaceutical Research,2016,35(6):361-363[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3255times   Download 2620次 QR Code for this article
Scan with your phone!
2005~2014年头孢菌素类抗生素致药源性死亡的国内文献分析
魏怡雯,邱菡
Font:Larger+|Default|Smaller-
(深圳市第二人民医院药剂科,广东 深圳 518035)
摘要:
目的 汇总近10年国内发表的报道头孢菌素类抗生素致药源性死亡的文献,分析国内头孢菌素类抗生素致药源性死亡的发生情况及特点,为临床用药安全提供科学依据。方法 检索中国知网、万方数据库和维普网中有关头孢菌素类抗生素致药源性死亡的文献资料,对致死病例的性别、年龄、ADR临床表现及死亡原因等信息进行回顾性分析。结果 纳入有效文献55篇,共报道病例76例,男性45例(59.2%)、女性31例(40.8%),男女性别比为1.45:1;患者年龄0.5~79岁,平均年龄46.9±17.9。患者原发疾病以上呼吸道感染29例(38.2%)、(支)气管炎12例(15.8%)、肺部感染11例(14.5%)等呼吸系统疾病为主,给药方式以静脉滴注为主,有65例(85.5%)。ADR的发生时间主要集中在10 min以内,有48例(63.2%);全部ADR患者中发生过敏性休克患者59例(77.6%),用药后休克症状发生时间<5 min有46例(78.0%)。第三代头孢菌素的使用率最高,有49例(64.5%)。全部患者ADR的临床表现及死亡原因分布中,过敏性休克占比最多59例(77.6%)。结论 头孢菌素类抗生素临床应用广泛,所引起的ADR临床表现各异,其中致药源性死亡的最主要原因为过敏性休克,第三代头孢菌素的使用率最高。临床用药过程中,用药前应当详细询问病史、过敏史等,密切观察防止ADR致死病例的发生。
关键词:  头孢菌素  药源性死亡  文献调查
DOI:10.13506/j.cnki.jpr.2016.06.017
基金项目:
Analysis of literatures about drug-induced death caused by cephalosporins from 2005 to 2014
WEI Yiwen,QIU Han
(Shenzhen No.2 People's Hospital,Shenzhen 518035,China)
Abstract:
Objective To analyze literatures about drug-induced death caused by cephalosporins,investigate the characteristics of drug-induced deaths by cephalosporins and provide a scientific basis for drug safety.Methods To retrieve literatures related cephalosporins cause drug-induced death in Chinese Knowledge Reseurce Integrated Database,Wanfang Data and VIP Network,and retrospectively analysis by sex,age,clinical manifestations of adverse drug reactions and cause of death and other information.Results There were 55 effective documents of 76 cases, 45 males (59.2%),31 females (40.8%),and the ratio was 1.45:1;Patients aged 0.5 to 79 years,the mean age was 46.9±17.9. Patients with primary disease 29 cases of upper respiratory tract infection (38.2%),12 cases of tracheitis(bronchitis) (15.8%),lung infection in 11 patients (14.5%),and other respiratory diseases mainly with intravenous administration of Lord,there were 65 cases (85.5%).ADR occurrence time,mainly within 10 min,there were 48 cases (63.2%);59 cases of anaphylactic shock patients (77.6%) occurred in patients of all ADR,shock symptoms occur after administration time <5 minutes,46 patients (78.0%).Highest third-generation cephalosporin usage,there are 49 cases(64.5%);the most frequently used before 5 cephalosporins were:ceftriaxone,cefazolin,cefoperazone,cefotaxime sodium,cefoperazone-sulbactam.Clinical manifestations of adverse reactions in all patients and cause of death distribution, accounting for up to anaphylactic shock 59 cases (77.6%).Conclusion The clinical application of antibiotics was widespread,the clinical manifestations of ADR were different, and the main cause of the death of drug was allergic shock,and the use of the third generation of the most important was the highest.In the process of clinical medication,the medical history,allergic history, etc.,should be closely observed to prevent the occurrence of ADR fatal cases.
Key words:  Cephalosporins  Drug induced death  Literature survey
Today's Visits:527    Total Visits:2383269
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.